News beats

DemeRx Appoints Michael Snitkovsky as Chief Operating Officer to Advance Clinical Pipeline

DemeRx Taps Michael Snitkovsky as New COO

DemeRx Announces FDA Acceptance of IND Application to Advance DMX-1001 for the Treatment of Alcohol Use Disorder (AUD)

DemeRx Welcomes E. Matthew “Whiz” Buckley to Advisory Board

Addressing the addiction and mental health crises in the United States

Ibogaine and Noribogaine: Mechanisms and Therapeutic Potential as Addiction Medicines

Exploring the Future of VR and Digital Therapeutics

The Unparalleled Power of Ibogaine in Addiction Recovery With Tom Feegel, CEO of Beond

Breaking the Cycle of Addiction with Ibogaine

Ibogaine Receives Serious Media Attention